Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
3.148.117.237

Continuous flow synthesis of the URAT1 inhibitor lesinurad

By Damião, Mariana C. F. C. B.; Marçon, Henrique M.; Pastre, Julio Cezar

Published on

Abstract

Herein, the urate anion exchange transporter 1 (URAT1) inhibitor lesinurad is synthesized from commercially available building blocks by a five-step linear continuous flow sequence. Our previously developed continuous flow platform was successfully applied to generate the 3-thio-1,2,4-triazole key intermediate 2 in 88% yield, after 55 minutes of residence time. Condensation, cyclization and S-alkylation were telescoped in a single operation without conducting solvent exchanges and intermediate purifications. Next, 1,2,4-triazole bromination and ester hydrolysis were also performed in continuous flow regime to deliver lesinurad in 68% overall yield in a total residence time of 2 hours. Our approach enables the fast generation of lesinurad and can be directly applied to produce major quantities of this important API.

Journal

Reaction Chemistry & Engineering. Volume 5, 2020, 865-872

DOI

10.1039/C9RE00483A

Type of publication

Peer-reviewed journal

Affiliations

  • University of Campinas 

Article Classification

Research Article

Classification Areas

  • API

Tags